🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Status
Recruiting
Location
Cancer Center of Guangzhou Medical University
Start Date
2025-06-24
Trial ID
NCT07070479
Overall, although there are many options for second-line treatment of liver...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2024-07-20
Trial ID
NCT06475287
Treatments Being Tested
This is an open-label, multicenter, randomized, phase 3 trial to evaluate t...
Status
Unknown
Location
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Start Date
2022-02-15
Trial ID
NCT05244642
Treatments Being Tested
This is a single-arm, open-label clinical trial evaluating the safety and p...
Status
Recruiting
Location
Blood diseases hospital
Start Date
2026-05-08
Trial ID
NCT07490288
This is a multicentre, open-label, single-arm, phase I/II clinical study to...
Status
Terminated
Location
the Affiliated Cancer Hospital of Guizhou Medical University
Start Date
2020-09-15
Trial ID
NCT04509466
The goal of this clinical trial is to estimate the rate (probability) of co...
Status
Recruiting
Location
First Affiliated Hospital Of University of Science and Technology of China
Start Date
2024-01-01
Trial ID
NCT06221683
The purpose of this study is to evaluate the tolerability, safety, pharmaco...
Status
Unknown
Location
Multiple Locations
Start Date
2022-04
Trial ID
NCT05344742
Treatments Being Tested
This is a multicentre, open-label, single-arm, phase Ib clinical study to e...
Status
Terminated
Location
Sun Yat-sen University Cancer Center
Start Date
2020-12-24
Trial ID
NCT04548700
A clinical study was conducted to evaluate the efficacy and safety of the R...
Status
Unknown
Location
The First Bethune Hospital of Jilin University
Start Date
2023-09-01
Trial ID
NCT05990985
to observe the dose-limiting toxicity (DLT) of liposomal mitoxantrone hydro...
Status
Recruiting
Location
The First Affiliated Hospital of Xiamen University
Start Date
2024-12-12
Trial ID
NCT06651866
Treatments Being Tested